'Tb drug' presentation slideshows

TB Drug Development

370 views • 33 slides

James Love Consumer Project on Technology cptech

339 views • 26 slides

Development of Country-Specific Plans for TB Drug Selection and Use

Development of Country-Specific Plans for TB Drug Selection and Use Bangladesh, India, Kenya, Philippines, and Uzbekistan. TB Drug Selection: Bangladesh. NTC needs consensus building for FDCs. Technical assistance is required STGs need to be revised

328 views • 24 slides

PDPs and Alternative IP Management/Tech Transfer Strategies for Improved Global Health

PDPs and Alternative IP Management/Tech Transfer Strategies for Improved Global Health Gerald J. Siuta, Ph.D. Consultant, Business Development Biotechnology Industry Organization Annual Meeting Atlanta, GA May 20, 2009.

247 views • 24 slides

Working Group on TB Drugs

Working Group on TB Drugs. Developing A Faster Cure. Maria C. Freire, Ph.D. Chair. Working Group Coordination. Treatment Today. Treatment Tomorrow. DOTS-Plus MDR-TB. New TB Vaccines. HIV/TB. DOTS Expansion. New TB Drugs. New TB Diagnostics. Mission.

354 views • 23 slides

PROGRESS & MAIN CHALLENGES IN TB DRUG R&D

PROGRESS & MAIN CHALLENGES IN TB DRUG R&D. Expert consultation Geneva 11 Apr 2008. Martina Casenghi, PhD Biologist. An improved landscape for TB drug R&D. Establishment of TB Alliance in 2000-Associated approximately with half of projects in the pipeline.

365 views • 22 slides

PROGRESS & MAIN CHALLENGES IN TB DRUG R&D

PROGRESS & MAIN CHALLENGES IN TB DRUG R&D. Expert consultation Geneva 11 Apr 2008. Martina Casenghi, PhD Biologist. An improved landscape for TB drug R&D. Establishment of TB Alliance in 2000-Associated approximately with half of projects in the pipeline.

319 views • 22 slides

PROGRESS & MAIN CHALLENGES IN TB DRUG R&D

PROGRESS & MAIN CHALLENGES IN TB DRUG R&D. Expert consultation Geneva 11 Apr 2008. Martina Casenghi, PhD Biologist. An improved landscape for TB drug R&D. Establishment of TB Alliance in 2000-Associated approximately with half of projects in the pipeline.

224 views • 22 slides

The Global Alliance for TB Drug Development Gerald J. Siuta, Ph.D., CLP

The Global Alliance for TB Drug Development Gerald J. Siuta, Ph.D., CLP Consultant, Business Development Global Alliance for TB Drug Development Biotechnology Industry Organization International Convention Chicago, IL May 4, 2010.

209 views • 20 slides

The TB Alliance-Bayer Moxifloxacin Deal

195 views • 19 slides

Introducing fixed dose combination tablets into DR CONGO using the Global TB Drug Facility

Introducing fixed dose combination tablets into DR CONGO using the Global TB Drug Facility. 20 provincial agencies. POO. POC. EQN. POE. EQS. KVN. MAN. BNN. KVS. KIN-UE. SAN. KOR. KM. BCO. 0. 200. KTN. BCE. BNS. BNO. KOC. KTS. KTO.

304 views • 17 slides

Developing New Drugs to Control TB

Developing New Drugs to Control TB. William Wells, Ph.D. Director, Market Access Global Alliance for TB Drug Development (TB Alliance) Journalist to Journalist Project, IUATLD Meeting Cancun, Mexico, December 4, 2009. The need for new TB drugs.

274 views • 16 slides